Cargando…

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant

This case series study assesses whether a fourth dose of a SARS-CoV-2 messenger RNA (mRNA)–based vaccine is associated with improved anti–SARS-CoV-2 antibody response in solid organ transplant recipients in France.

Detalles Bibliográficos
Autores principales: Kamar, Nassim, Abravanel, Florence, Marion, Olivier, Romieu-Mourez, Raphaelle, Couat, Chloé, Del Bello, Arnaud, Izopet, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613594/
https://www.ncbi.nlm.nih.gov/pubmed/34817587
http://dx.doi.org/10.1001/jamanetworkopen.2021.36030
_version_ 1784603670773497856
author Kamar, Nassim
Abravanel, Florence
Marion, Olivier
Romieu-Mourez, Raphaelle
Couat, Chloé
Del Bello, Arnaud
Izopet, Jacques
author_facet Kamar, Nassim
Abravanel, Florence
Marion, Olivier
Romieu-Mourez, Raphaelle
Couat, Chloé
Del Bello, Arnaud
Izopet, Jacques
author_sort Kamar, Nassim
collection PubMed
description This case series study assesses whether a fourth dose of a SARS-CoV-2 messenger RNA (mRNA)–based vaccine is associated with improved anti–SARS-CoV-2 antibody response in solid organ transplant recipients in France.
format Online
Article
Text
id pubmed-8613594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-86135942021-12-08 Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant Kamar, Nassim Abravanel, Florence Marion, Olivier Romieu-Mourez, Raphaelle Couat, Chloé Del Bello, Arnaud Izopet, Jacques JAMA Netw Open Research Letter This case series study assesses whether a fourth dose of a SARS-CoV-2 messenger RNA (mRNA)–based vaccine is associated with improved anti–SARS-CoV-2 antibody response in solid organ transplant recipients in France. American Medical Association 2021-11-24 /pmc/articles/PMC8613594/ /pubmed/34817587 http://dx.doi.org/10.1001/jamanetworkopen.2021.36030 Text en Copyright 2021 Kamar N et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Kamar, Nassim
Abravanel, Florence
Marion, Olivier
Romieu-Mourez, Raphaelle
Couat, Chloé
Del Bello, Arnaud
Izopet, Jacques
Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
title Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
title_full Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
title_fullStr Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
title_full_unstemmed Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
title_short Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
title_sort assessment of 4 doses of sars-cov-2 messenger rna–based vaccine in recipients of a solid organ transplant
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613594/
https://www.ncbi.nlm.nih.gov/pubmed/34817587
http://dx.doi.org/10.1001/jamanetworkopen.2021.36030
work_keys_str_mv AT kamarnassim assessmentof4dosesofsarscov2messengerrnabasedvaccineinrecipientsofasolidorgantransplant
AT abravanelflorence assessmentof4dosesofsarscov2messengerrnabasedvaccineinrecipientsofasolidorgantransplant
AT marionolivier assessmentof4dosesofsarscov2messengerrnabasedvaccineinrecipientsofasolidorgantransplant
AT romieumourezraphaelle assessmentof4dosesofsarscov2messengerrnabasedvaccineinrecipientsofasolidorgantransplant
AT couatchloe assessmentof4dosesofsarscov2messengerrnabasedvaccineinrecipientsofasolidorgantransplant
AT delbelloarnaud assessmentof4dosesofsarscov2messengerrnabasedvaccineinrecipientsofasolidorgantransplant
AT izopetjacques assessmentof4dosesofsarscov2messengerrnabasedvaccineinrecipientsofasolidorgantransplant